UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000004010
Receipt No. R000004821
Scientific Title Efficacy and safety of combination therapy with vildagliptin and nateglinide in type 2 diabetes.
Date of disclosure of the study information 2010/09/30
Last modified on 2013/06/19 11:51:03

No. Disposal Last modified on Item of update
1 Insert 2010/08/06 17:54:48
2 Update 2010/09/10 11:44:32 Public title
Public title
Acronym
Acronym
3 Update 2010/09/10 11:47:28 Narrative objectives1
Narrative objectives1
Primary outcomes
Primary outcomes
4 Update 2010/09/10 11:48:56 Interventions/Control_1
Interventions/Control_1
Interventions/Control_2
Interventions/Control_2
5 Update 2010/09/10 11:50:21 Organization
Organization
6 Update 2010/09/10 11:51:07 Date of protocol fixation
Anticipated trial start date
7 Update 2010/09/10 12:05:05 Key exclusion criteria
8 Update 2010/10/07 17:57:14 Organization
Organization
Category of Funding Organization
9 Update 2010/10/08 10:21:06 Primary outcomes
Primary outcomes
Key secondary outcomes
Key secondary outcomes
10 Update 2011/02/07 16:26:14 Recruitment status
Anticipated trial start date
11 Update 2011/03/07 11:02:53 Last follow-up date
12 Update 2011/03/07 11:04:47 Email1
13 Update 2011/06/25 21:58:35 Organization
Organization
Post marketing survey by drug manufacture etc., specified by Japanese law.
14 Update 2011/06/25 21:59:06 Recruitment status
15 Update 2012/06/02 12:05:10 Recruitment status
16 Update 2013/06/19 11:51:03
Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria


Contact us.